-
Awarded03/09/2026
-
Today07/10/2026
Utilities
- indicates text translated automatically in your browsing language
Medicinal product discount agreement pursuant to § 130a(8) SGB V in conjunction with § 130c(1) SGB V for the medicinal products Haemate P (B02BD06) and Voncento (B02BD06) for the treatment of haemophilia
AOK Sachsen-Anhalt concluded a contract with the manufacturer of the medicinal products Haemate P (B02BD06) and Voncento (B02BD06) for the treatment of haemophilia with effect from 1 September 26 in accordance with Paragraph 130a(8) of the SGB V in conjunction with Paragraph 130c(1) of the SGB V.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.